Hyperfine, Inc. (NASDAQ:HYPR) Receives Average Rating of “Hold” from Brokerages

Shares of Hyperfine, Inc. (NASDAQ:HYPR) have earned an average recommendation of “Hold” from the six ratings firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $1.7833.

Several equities research analysts recently weighed in on the stock. B. Riley Financial reaffirmed a “buy” rating on shares of Hyperfine in a research report on Wednesday, May 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research report on Tuesday, April 21st. Lake Street Capital upped their price objective on shares of Hyperfine from $2.00 to $2.50 and gave the stock a “buy” rating in a research report on Thursday, March 19th. BTIG Research assumed coverage on shares of Hyperfine in a research report on Wednesday, April 29th. They set a “buy” rating and a $2.00 price objective for the company. Finally, Zacks Research raised shares of Hyperfine to a “hold” rating in a research report on Thursday, March 19th.

Hyperfine Trading Up 0.3%

HYPR stock opened at $1.48 on Monday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 4.90 and a current ratio of 5.52. The company’s 50-day simple moving average is $1.49 and its 200 day simple moving average is $1.25. Hyperfine has a 52 week low of $0.68 and a 52 week high of $2.22. The company has a market capitalization of $146.42 million, a PE ratio of -3.60 and a beta of 1.38.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.09) EPS for the quarter, meeting the consensus estimate of ($0.09). Hyperfine had a negative net margin of 226.88% and a negative return on equity of 98.83%. The business had revenue of $3.90 million for the quarter, compared to the consensus estimate of $3.54 million. As a group, sell-side analysts anticipate that Hyperfine will post -0.34 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its holdings in shares of Hyperfine by 5.7% in the third quarter. Vanguard Group Inc. now owns 3,511,972 shares of the company’s stock worth $5,092,000 after acquiring an additional 190,136 shares during the last quarter. Catalio Capital Management LP increased its position in Hyperfine by 92.8% during the 4th quarter. Catalio Capital Management LP now owns 1,320,041 shares of the company’s stock valued at $1,293,000 after purchasing an additional 635,500 shares during the period. Geode Capital Management LLC increased its position in Hyperfine by 21.4% during the 4th quarter. Geode Capital Management LLC now owns 815,986 shares of the company’s stock valued at $799,000 after purchasing an additional 143,975 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Hyperfine by 100.2% during the 1st quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after buying an additional 365,490 shares in the last quarter. Finally, State Street Corp boosted its holdings in shares of Hyperfine by 6.1% during the 4th quarter. State Street Corp now owns 265,195 shares of the company’s stock worth $260,000 after buying an additional 15,200 shares in the last quarter. Institutional investors own 15.03% of the company’s stock.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.